Claritas Pharmaceuticals is developing R-107, a nitric oxide releasing molecule designed to treat vaccine-resistant COVID-19 infection. Nitric oxide is the immune system's first line of defense against viral infection. When a viral threat is present, white blood cells migrate to the area of infectio...
Use this information to figure out if this company is an ideal customer for you.
888.861.2008
4040 Civic Center Drive
San Francisco
Claritas Pharmaceuticals's CEO is Robert Farrell
Claritas Pharmaceuticals's HQ is located at 4040 Civic Center Drive, San Francisco
Claritas Pharmaceuticals's phone number is 888.861.2008
Claritas Pharmaceuticals's official website is claritaspharma.com
Claritas Pharmaceuticals's revenue is $5M - $20M
Claritas Pharmaceuticals has 11 - 50 employees
Claritas Pharmaceuticals is in the industry of: Pharmaceuticals